HJ, I., J, R., AV, B., HB, S., L, K., S, F., . . . AH, W. (2025). ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL. Blood advances, 9(6), 1476. https://doi.org/10.1182/bloodadvances.2024015397
Chicago Style (17th ed.) CitationHJ, Iland, et al. "ALLG APML5: Bioavailability and Safety of Oral Arsenic Trioxide Assessed During Consolidation Therapy for APL." Blood Advances 9, no. 6 (2025): 1476. https://doi.org/10.1182/bloodadvances.2024015397.
MLA (9th ed.) CitationHJ, Iland, et al. "ALLG APML5: Bioavailability and Safety of Oral Arsenic Trioxide Assessed During Consolidation Therapy for APL." Blood Advances, vol. 9, no. 6, 2025, p. 1476, https://doi.org/10.1182/bloodadvances.2024015397.
Warning: These citations may not always be 100% accurate.
